These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 38551928

  • 1. Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
    Thangaraj JWV, Prosperi C, Kumar MS, Hasan AZ, Kumar VS, Winter AK, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Soman B, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sarmah NP, Sharma S, Varghese A, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Chonker SK, Sangal L, Mehendale SM, Sapkal GN, Gupta N, Hayford K, Moss WJ, Murherkar MV.
    PLoS One; 2024; 19(3):e0297385. PubMed ID: 38551928
    [Abstract] [Full Text] [Related]

  • 2. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
    Prosperi C, Thangaraj JWV, Hasan AZ, Kumar MS, Truelove S, Kumar VS, Winter AK, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Soman B, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sharma NP, Sharma S, Varghese A, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Chonker SK, Cutts FT, Sangal L, Mehendale SM, Sapkal GN, Gupta N, Hayford K, Moss WJ, Murhekar MV.
    Vaccine; 2023 Jan 09; 41(2):486-495. PubMed ID: 36481106
    [Abstract] [Full Text] [Related]

  • 3. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
    Danovaro-Holliday MC, Rhoda DA, Lacoul M, Prier ML, Gautam JS, Pokhrel TN, Dixit SM, Rajbhandari RM, Bose AS.
    BMC Public Health; 2022 Feb 03; 22(1):221. PubMed ID: 35114969
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ, Adhikary G, Ali MW, Ahmed S, Shamsuzzaman M, Odell C, Hashiguchi L, Lim SS, Alam N.
    BMC Infect Dis; 2016 Aug 12; 16():411. PubMed ID: 27519586
    [Abstract] [Full Text] [Related]

  • 5. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A, Vincent A, Selvaraj K, Manikandan M.
    Rural Remote Health; 2019 Sep 12; 19(3):5261. PubMed ID: 31529972
    [Abstract] [Full Text] [Related]

  • 6. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.
    Murhekar MV, Gupta N, Hasan AZ, Kumar MS, Kumar VS, Prosperi C, Sapkal GN, Thangaraj JWV, Kaduskar O, Bhatt V, Deshpande GR, Thankappan UP, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sharma S, Sarmah NP, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Shrivastava AK, Chonker SK, Tilekar B, Tandale BV, Ahmad M, Sangal L, Winter A, Mehendale SM, Moss WJ, Hayford K.
    Lancet Glob Health; 2022 Nov 12; 10(11):e1655-e1664. PubMed ID: 36240831
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of vaccination coverage of measles-rubella campaign in Imphal East District, Manipur: A cross-sectional study.
    Rajkumari B, Keisam A, Haobam DS, Thounaojam T.
    Indian J Public Health; 2020 Nov 12; 64(2):173-177. PubMed ID: 32584301
    [Abstract] [Full Text] [Related]

  • 8. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S, Tabu C, N'ganga J, Awes AA, Sergon K, Cosmas L, Styczynski A, Thuo S, Lebo E, Kaiser R, Perry R, Ademba P, Kretsinger K, Onuekwusi I, Gary H, Scobie HM.
    PLoS One; 2018 Nov 12; 13(7):e0199786. PubMed ID: 29965975
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting non-coverage of measles-rubella vaccination among children aged 9-59 months in Tanzania.
    Mkopi A, Mtenga S, Festo C, Mhalu G, Shabani J, Tillya R, Masemo A, Kheir K, Nassor M, Mwengee W, Lyimo D, Masanja H.
    Vaccine; 2021 Oct 01; 39(41):6041-6049. PubMed ID: 34531077
    [Abstract] [Full Text] [Related]

  • 10. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA, François J, Wannemuehler K, Magloire R, Danovaro-Holliday MC, Flannery B, Cavallaro KF, Fitter DL, Purcell N, Dismer A, Tappero JW, Vertefeuille JF, Hyde TB.
    Trop Med Int Health; 2014 Sep 01; 19(9):1105-15. PubMed ID: 25041586
    [Abstract] [Full Text] [Related]

  • 11. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [Abstract] [Full Text] [Related]

  • 12. Social capital, trust in health information, and acceptance of Measles-Rubella vaccination campaign in Tamil Nadu: A case-control study.
    Palanisamy B, Gopichandran V, Kosalram K.
    J Postgrad Med; 2018 Sep 01; 64(4):212-219. PubMed ID: 29943738
    [Abstract] [Full Text] [Related]

  • 13. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ, Orenstein WA.
    Vaccine; 2018 Sep 05; 36(37):5645-5650. PubMed ID: 30041881
    [Abstract] [Full Text] [Related]

  • 14. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec 05; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 15. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016.
    Ismail A, Tabu C, Onuekwusi I, Otieno SK, Ademba P, Kamau P, Koki B, Ngatia A, Wainaina A, Davis R.
    Pan Afr Med J; 2017 Dec 05; 27(Suppl 3):16. PubMed ID: 29296151
    [Abstract] [Full Text] [Related]

  • 16. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [Abstract] [Full Text] [Related]

  • 17. Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India.
    Salvi N, Itta KC, Lachyan A, Hasan AZ, Prosperi C, Kumar MS, Wesley Vivian Thangaraj J, Kaduskar O, Bhatt V, Sapkal GN, Murhekar M, Gupta N, Mehendale S, Hayford K, Moss WJ, Chauhan S, Kulkarni R.
    PLoS One; 2022 Sep 01; 17(8):e0271920. PubMed ID: 35925959
    [Abstract] [Full Text] [Related]

  • 18. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC, Mutembo S, Matakala KH, Chilumba I, Mulundu G, Monze M, Mwansa FD, Moss WJ, Hayford K.
    Am J Trop Med Hyg; 2021 May 03; 104(6):2229-2232. PubMed ID: 33939639
    [Abstract] [Full Text] [Related]

  • 19. Cost of conducting Measles-Rubella vaccination campaign in India.
    Chatterjee S, Song D, Das P, Haldar P, Ray A, Brenzel L, Boonstoppel L, Mogasale V.
    Hum Vaccin Immunother; 2022 Dec 31; 18(1):1-8. PubMed ID: 34411494
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting vaccination demand in Indonesia: a secondary analysis and multimethods national assessment.
    Jusril H, Rachmi CN, Amin MR, Dynes M, Sitohang V, Untung ASB, Damayanti R, Ariawan I, Pronyk PM.
    BMJ Open; 2022 Aug 11; 12(8):e058570. PubMed ID: 35953251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.